Oklahoma 2024 Regular Session

Oklahoma Senate Bill SB232 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 1 1
	3	+	SB232 HFLR Page 1
	4	+	BOLD FACE denotes Committee Amendments. 1
4	5		2
5	6		3
6	7		4
7	8		5
8	9		6
9	10		7
10	11		8
11	12		9
12	13		10
13	14		11
14	15		12
15	16		13
16	17		14
17	18		15
18	19		16
19	20		17
20	21		18
21	22		19
22	23		20
23	24		21
24	25		22
25	26		23
26	27		24
27	28
28		-	ENGROSSED HOUSE AMENDME NT
29		-	TO
30		-	ENGROSSED SENATE BILL NO . 232 By: Garvin of the Senate
	29	+	HOUSE OF REPRESENTATIVES - FLOOR VERSION
	30	+
	31	+	STATE OF OKLAHOMA
	32	+
	33	+	2nd Session of the 59th Legislature (2024)
	34	+
	35	+	COMMITTEE SUBSTITUTE
	36	+	FOR ENGROSSED
	37	+	SENATE BILL NO. 232 By: Garvin of the Senate
31	38
32	39		and
33	40
34	41		McEntire of the House
35	42
36	43
37	44
38	45
39	46
40		-	~~[ pharmacy - technicians - ratio - effective date ]~~
	47	+	COMMITTEE SUBSTITUTE
41	48
42		-
43		-
44		-	NOTE: Emergency failed
45		-
46		-	AUTHORS: Remove Senator Garvin as principal Senate a uthor and
47		-	substitute with Senator Seifried
48		-
49		-	Add as coauthor Senator Garvin
50		-
51		-
52		-	AMENDMENT NO. 1. Strike the stricken title, enacting clause, and
53		-	entire bill and insert:
	49	+	An Act relating to the practice of pharmacy; allowing
	50	+	pharmacist to test or screen for and initiate drug
	51	+	therapy for minor, nonchronic health conditions;
	52	+	specifying allowed tests; allowing pharmacist to
	53	+	dispense certain produ cts under certain protocol;
	54	+	directing adoption of rules; amending 59 O.S. 2021,
	55	+	Section 353.1, as amended by Section 6, Chapter 288,
	56	+	O.S.L. 2022 (59 O.S. Supp. 2023, Section 353.1),
	57	+	which relates to definitions used in the Oklahoma
	58	+	Pharmacy Act; modifying and adding definitions;
	59	+	amending 59 O.S. 2021, Section 353.18A, which relates
	60	+	to pharmacy technicians; establishing certain
	61	+	pharmacy ratio; updating statutory lan guage and
	62	+	references; providing for codification; providing an
	63	+	effective date; and declaring an emergency.
54	64
55	65
56	66
57	67
58		-	"An Act relating to the practice of pharmacy;
59		-	allowing pharmacist to test or screen for and
60		-	initiate drug therapy for minor, nonchronic health
61		-	conditions; specifying allowed tests; allowing
62		-	pharmacist to dispense certain produ cts under certain
63		-	protocol; directing adoption of rules; amending 59
64		-	O.S. 2021, Section 353.1, as amended by Section 6,
65		-	Chapter 288, O.S.L. 2022 (59 O.S. Supp. 2023, Section
66		-	353.1), which relates to definitions used in the
67		-	Oklahoma Pharmacy Act; modifying and adding
68		-	definitions; amending 59 O.S. 2021, Section 353.18A,
69		-	which relates to pharmacy technicians; establishing
70		-	certain pharmacy rat io; updating statutory lan guage
71		-	and references; and providing for codification.
72	68
	69	+	BE IT ENACTED BY THE PEO PLE OF THE STATE OF OKLAHOMA:
	70	+	SECTION 1. NEW LAW A new section of law to be codified
	71	+	in the Oklahoma Statutes as Section 353.31 of Title 59, unless there
	72	+	is created a duplication i n numbering, reads as follows:
73	73
74		-
75		-
76		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 2 1
	74	+	SB232 HFLR Page 2
	75	+	BOLD FACE denotes Committee Amendments. 1
77	76		2
78	77		3
79	78		4
80	79		5
81	80		6
82	81		7
83	82		8
84	83		9
85	84		10
86	85		11
87	86		12
88	87		13
89	88		14
90	89		15
91	90		16
92	91		17
93	92		18
94	93		19
95	94		20
96	95		21
97	96		22
98	97		23
99	98		24
100	99
101		-	BE IT ENACTED BY THE PEO PLE OF THE STATE OF OKLAHOMA:
102		-	SECTION 1. NEW LAW A new section of law to be codified
103		-	in the Oklahoma Statutes as Section 353.31 of Title 59, unless there
104		-	is created a duplication i n numbering, reads as follows:
105	100		A. A pharmacist may test or screen for and initiate drug
106	101		therapy for minor, nonchronic health conditions as defined in
107	102		Section 353.1 of Title 59 of the Oklahoma Stat utes.
108	103		B. To test for minor, nonchronic he alth conditions under this
109	104		section, the pharmacist may use any test that may guide clinical
110	105		decision-making and that is:
111	106		1. Approved by, cleared by, or authorized under an emergency
112	107		use authorization by the United States Food and Drug Administration;
113	108		and
114	109		2. Waived under the federa l Clinical Laboratory Improvement
115	110		Amendments of 1988 (CLIA) or deemed to be CLIA-waived for use in
116	111		patient care settings operating under a CLIA certificate.
117	112		C. A pharmacist may dispense self-administered hormonal
118	113		contraceptives under the protocol es tablished pursuant to subsection
119		-	E of this section, regardless of whether the patient has obtained a
	114	+	D of this section, regardless of whether the patient has obtained a
120	115		prescription.
121	116		D. A pharmacist may not test or screen for streptococcus and
122	117		initiate drug therapy for streptococcus to individuals under six (6)
123	118		years of age.
	119	+	E. The State Board of Pharmacy shall adopt rules establishing a
	120	+	protocol for dispensing self-administered hormonal contraceptives by
	121	+	January 1, 2025.
124	122
125		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 3 1
	123	+	SB232 HFLR Page 3
	124	+	BOLD FACE denotes Committee Amendments. 1
126	125		2
127	126		3
128	127		4
129	128		5
130	129		6
131	130		7
132	131		8
133	132		9
134	133		10
135	134		11
136	135		12
137	136		13
138	137		14
139	138		15
140	139		16
141	140		17
142	141		18
143	142		19
144	143		20
145	144		21
146	145		22
147	146		23
148	147		24
149	148
150		-	E. The State Board of Pharmacy shall adopt rules establishing a
151		-	protocol for dispensing self-administered hormonal contraceptives by
152		-	January 1, 2025.
153	149		SECTION 2. AMENDATORY 59 O.S. 2021, Section 353.1, as
154	150		amended by Section 6 , Chapter 288, O.S.L. 2022 (59 O.S. Supp. 2023,
155	151		Section 353.1), is amended to read as follows:
156	152		Section 353.1 For the purposes of the Oklahoma Pharmacy Act:
157	153		1. “Accredited program” means those seminars, classes,
158	154		meetings, work projects, and oth er educational courses approved by
159	155		the State Board of Pharmacy for purposes of continuing professional
160	156		education;
161	157		2. “Act” means the Oklahoma Pharmacy Act;
162	158		3. “Administer” means the direct application of a drug, whether
163	159		by injection, inhalation, ingestion or any other means, to the body
164	160		of a patient;
165	161		4. “Assistant pharmacist” means any person presently licensed
166	162		as an assistant pharmacist in the State of Oklahom a this state by
167	163		the Board pursuant to Section 353.10 of this title and for the
168	164		purposes of the Okla homa Pharmacy Act shall be considered the same
169	165		as a pharmacist, except where otherwise specified;
170	166		5. “Board” or “State Board” means the State Board of Pharmacy;
171	167		6. “Certify” or “certification of a prescription” means the
172	168		review of a filled prescription b y a licensed pharmacist or a
173	169		licensed practitioner with dispensing authority to confirm that the
	170	+	medication, labeling and packaging of the filled prescription are
	171	+	accurate and meet all requirements prescribed by state and federal
174	172
175		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 4 1
	173	+	SB232 HFLR Page 4
	174	+	BOLD FACE denotes Committee Amendments. 1
176	175		2
177	176		3
178	177		4
179	178		5
180	179		6
181	180		7
182	181		8
183	182		9
184	183		10
185	184		11
186	185		12
187	186		13
188	187		14
189	188		15
190	189		16
191	190		17
192	191		18
193	192		19
194	193		20
195	194		21
196	195		22
197	196		23
198	197		24
199	198
200		-	medication, labeling and packaging of the filled prescription are
201		-	accurate and meet all requirements prescribed by state and federal
202	199		law. For the purposes of this paragraph, “licensed practitioner”
203	200		shall not include optometrists with dispensing authority;
204	201		7. “Chemical” means any medicinal substance, whether simple or
205	202		compound or obtained through the process of the science and art of
206	203		chemistry, whether of organ ic or inorganic origin;
207	204		8. “Compounding” means the combining, admixing, mixing,
208	205		diluting, pooling, reconstituting or otherwise altering of a drug or
209	206		bulk drug substance to create a drug. Compounding includes the
210	207		preparation of drugs or devices in anticip ation of prescription drug
211	208		orders based on routine, regularly observed prescribing patterns;
212	209		9. “Continuing professional education” means professional,
213	210		pharmaceutical education in the general areas of the socioeconomic
214	211		and legal aspects of health care; th e properties and actions of
215	212		drugs and dosage forms; and the etiology, characteristics and
216	213		therapeutics of the diseased state;
217	214		10. “Dangerous drug”, “legend drug”, “prescription drug” or “Rx
218	215		Only” means a drug:
219		-	a. for human use subject to 21 U.S.C. , Section 353(b)(1),
	216	+	a. for human use subject to 21 U.S.C. Section 353(b)(1),
220	217		or
221	218		b. is labeled “Prescription Only”, or labeled with the
222	219		following statement: “Caution: Federal law restricts
	220	+	this drug except for to use by or on the order of a
	221	+	licensed veterinarian.”;
223	222
224		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 5 1
	223	+	SB232 HFLR Page 5
	224	+	BOLD FACE denotes Committee Amendments. 1
225	225		2
226	226		3
227	227		4
228	228		5
229	229		6
230	230		7
231	231		8
232	232		9
233	233		10
234	234		11
235	235		12
236	236		13
237	237		14
238	238		15
239	239		16
240	240		17
241	241		18
242	242		19
243	243		20
244	244		21
245	245		22
246	246		23
247	247		24
248	248
249		-	this drug except for to use by or on the order of a
250		-	licensed veterinarian.”;
251	249		11. “Director” means the Executive Director of the State Boar d
252	250		of Pharmacy unless context clearly indi cates otherwise;
253	251		12. “Dispense” or “dispensing” means the interpretation,
254	252		evaluation, and implementation of a prescription drug order
255	253		including the preparation and delivery of a drug or device to a
256	254		patient or a patient’s agent in a suitable container appr opriately
257	255		labeled for subsequent administration to, or use by, a patient.
258	256		Dispense includes sell, distribute, leave with, give away, dispose
259	257		of, deliver or supply;
260	258		13. “Dispenser” means a retail pharmacy, hospital pharmacy, a
261	259		group of chain pharmacies un der common ownership and control that do
262	260		not act as a wholesale distributor, or any other person authorized
263	261		by law to dispense or administer prescription drugs, and the
264	262		affiliated warehouses or distributions of such entities under common
265	263		ownership and control that do not act as a wholesale distributor.
266	264		For the purposes of this paragraph, “dispenser” dispenser does not
267	265		mean a person who dispenses only products to be used in animals in
268		-	accordance with 21 U.S.C. , Section 360b(a)(5);
	266	+	accordance with 21 U.S.C. Section 360b(a)(5);
269	267		14. “Distribute” or “distribution” means the sale, purchase,
270	268		trade, delivery, handling, storage, or receipt of a product, and
271	269		does not include the dispensing of a product pursuant to a
272		-	prescription executed in accordance with 21 U.S.C. , Section
	270	+	prescription executed in accordance with 21 U.S.C. Section 353(b)(1)
	271	+	or the dispensing of a pr oduct approved under 21 U.S.C. Section
273	272
274		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 6 1
	273	+	SB232 HFLR Page 6
	274	+	BOLD FACE denotes Committee Amendments. 1
275	275		2
276	276		3
277	277		4
278	278		5
279	279		6
280	280		7
281	281		8
282	282		9
283	283		10
284	284		11
285	285		12
286	286		13
287	287		14
288	288		15
289	289		16
290	290		17
291	291		18
292	292		19
293	293		20
294	294		21
295	295		22
296	296		23
297	297		24
298	298
299		-	353(b)(1) or the dispensing of a pr oduct approved under 21 U.S.C.,
300		-	Section 360b(b); provided, taking actual physical possession of a
301		-	product or title shall not be required;
	299	+	360b(b); provided, taking actual physical possession of a product or
	300	+	title shall not be required;
302	301		15. “Doctor of Pharmacy” means a person licensed by the Board
303	302		to engage in the practice of pharmacy. The terms “pharmacist”,
304	303		“D.Ph.”, and “Doctor of Pharmacy” shall be interchangeable and s hall
305	304		have the same meaning wherever they appear in the Oklahoma Statutes
306	305		and the rules promulgated by the Board;
307	306		16. “Drug outlet” means all manufacturers, repackagers,
308	307		outsourcing faciliti es, wholesale distributors, third-party
309	308		logistics providers, pharm acies, and all other facilities which are
310	309		engaged in dispensing, delivery, distribution or storage of
311	310		dangerous drugs;
312	311		17. “Drugs” means all medicinal substances and preparations
313	312		recognized by the United States Pharmacopoeia Pharmacopeia and
314	313		National Formulary, or any revision thereof, and all substances and
315	314		preparations intended for external and/or internal use in the cure,
316	315		diagnosis, mitigation, treatment or prevention of disease in humans
317	316		or animals and all substances and preparations, other than food,
318	317		intended to affect the structure or any function of the body of a
319	318		human or animals;
320	319		18. “Drug sample” means a unit of a prescription drug packaged
321	320		under the authority and responsibility of th e manufacturer that is
	321	+	not intended to be sold and is intended to promote the sale of the
	322	+	drug;
322	323
323		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 7 1
	324	+	SB232 HFLR Page 7
	325	+	BOLD FACE denotes Committee Amendments. 1
324	326		2
325	327		3
326	328		4
327	329		5
328	330		6
329	331		7
330	332		8
331	333		9
332	334		10
333	335		11
334	336		12
335	337		13
336	338		14
337	339		15
338	340		16
339	341		17
340	342		18
341	343		19
342	344		20
343	345		21
344	346		22
345	347		23
346	348		24
347	349
348		-	not intended to be sold and is intended to promote the sale of the
349		-	drug;
350	350		19. “Durable medical equipment” has the same meaning as
351	351		provided by Section 2 375.2 of this act title;
352	352		20. “Filled prescription” means a packaged pres cription
353	353		medication to which a label has been affixed which contains such
354	354		information as is required by the Oklahoma Pharmacy Act;
355	355		21. “Hospital” means any institution licensed as a hospital by
356	356		this state for the care and treatment of patients, or a pharm acy
357	357		operated by the Oklahoma Department of Veterans Affairs;
358	358		22. “Licensed practitioner” means an allopathic physician,
359	359		osteopathic physician, podiatric physician, dentist, veterinarian or
360	360		optometrist licensed to practice and authorized to prescribe
361	361		dangerous drugs within the scope of practice of such practitioner;
362	362		23. “Manufacturer” or “virtual manufacturer” means with respect
363	363		to a product:
364	364		a. a person that holds an application approved under 21
365		-	U.S.C., Section 355 or a license issued under 42
366		-	~~U.S.C.,~~ Section 262 for such product, or if such
367		-	~~product is~~ not the subject of an approved application
368		-	~~or license,~~ the person who manufactured the product,
	365	+	U.S.C. Section 355 or a license issued under 42 U.S.C.
	366	+	Section 262 for such product, or if such product is
	367	+	not the subject of an approved application or license,
	368	+	the person who manufactured the product,
369	369		b. a co-licensed partner of the person described in
370	370		subparagraph a of this paragraph that obtains the
	371	+	product directly from a person described in this
	372	+	subparagraph or subparagraph a of this paragraph,
371	373
372		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 8 1
	374	+	SB232 HFLR Page 8
	375	+	BOLD FACE denotes Committee Amendments. 1
373	376		2
374	377		3
375	378		4
376	379		5
377	380		6
378	381		7
379	382		8
380	383		9
381	384		10
382	385		11
383	386		12
384	387		13
385	388		14
386	389		15
387	390		16
388	391		17
389	392		18
390	393		19
391	394		20
392	395		21
393	396		22
394	397		23
395	398		24
396	399
397		-	product directly from a person described in this
398		-	subparagraph or subparagraph a of this paragraph,
399	400		c. an affiliate of a person described in subpara graph a
400	401		or b of this paragraph who receives the product
401	402		directly from a person described in this subparagraph
402	403		or in subparagraph a or b of this paragraph, or
403	404		d. a person who contracts with another to manufacture a
404	405		product;
405	406		24. “Manufacturing” means the production, preparation,
406	407		propagation, compounding, conversion or processing of a device or a
407	408		drug, either directly or indirectly by extraction from substances of
408	409		natural origin or independently by means of chemical or biological
409	410		synthesis and includes any pac kaging or repackaging of the
410	411		substances or labeling or relabeling of its container, and the
411	412		promotion and marketing of such drugs or devices. The term
412	413		“manufacturing” manufacturing also includes the preparation and
413	414		promotion of commercially avail able products from bulk compounds for
414	415		resale by licensed pharmacies, licensed practitioners or other
415	416		persons;
416	417		25. “Medical gas” means those gases including those in liquid
417	418		state upon which the manufacturer or distributor has placed one of
418	419		several cautions, such as “Rx Only”, in compliance with federal law;
419	420		26. “Medical gas order” means an order for medical gas issued
420	421		by a licensed prescriber;
	422	+	27. “Medical gas distributor” means a person licensed to
	423	+	distribute, transfer, wholesale, deliver or sell medical gases on
421	424
422		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 9 1
	425	+	SB232 HFLR Page 9
	426	+	BOLD FACE denotes Committee Amendments. 1
423	427		2
424	428		3
425	429		4
426	430		5
427	431		6
428	432		7
429	433		8
430	434		9
431	435		10
432	436		11
433	437		12
434	438		13
435	439		14
436	440		15
437	441		16
438	442		17
439	443		18
440	444		19
441	445		20
442	446		21
443	447		22
444	448		23
445	449		24
446	450
447		-	27. “Medical gas distributor” means a person licensed to
448		-	distribute, transfer, wholesale, deliver or sell medical gases on
449	451		drug orders to suppliers or oth er entities licensed to use,
450	452		administer or distribute medical gas and may also include a patient
451	453		or ultimate user;
452	454		28. “Medical gas supplier” means a person who disp enses medical
453	455		gases on drug orders only to a pati ent or ultimate user;
454	456		29. “Medicine” means any drug or combination of drugs which has
455	457		the property of curing, preventing, treating, diagnosing or
456	458		mitigating diseases, or which is used for that purpose;
457	459		30. “Minor, nonchronic health condition” means a typically
458	460		short-term health condition that is gener ally managed with
459	461		noncontrolled drug therapies, minimal treatment, or self-care, and
460	462		is limited to the following:
461	463		a. influenzas,
462	464		b. streptococcus,
463	465		c. SARS-CoV-2,
464	466		d. lice, and
465	467		e. other emerging and existing pub lic health threats
466	468		identified by the State Depa rtment of Health if
467	469		permitted by an order, rule, or regulation;
468	470		31. “Nonprescription drugs” means medicines or drugs which are
469	471		sold without a prescription and which are prepackaged for use by the
470	472		consumer and labeled in accordance with the requirements of the
	473	+	statutes and regulations of this state and the federal government.
	474	+	Such items shall also include medical a nd dental supplies and
471	475
472		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 10 1
	476	+	SB232 HFLR Page 10
	477	+	BOLD FACE denotes Committee Amendments. 1
473	478		2
474	479		3
475	480		4
476	481		5
477	482		6
478	483		7
479	484		8
480	485		9
481	486		10
482	487		11
483	488		12
484	489		13
485	490		14
486	491		15
487	492		16
488	493		17
489	494		18
490	495		19
491	496		20
492	497		21
493	498		22
494	499		23
495	500		24
496	501
497		-	statutes and regulations of this state and the federal government.
498		-	Such items shall also include medical a nd dental supplies and
499	502		bottled or nonbulk chemicals which are sold or offered for sale to
500	503		the general public if such articles or preparations meet the
501	504		requirements of the Federal Food, Drug and Cosmetic Act, 21
502	505		U.S.C.A., Section 321 et seq.;
503	506		31. 32. “Outsourcing facility” including “virtual outsourcing
504	507		facility” means a facility at one geographic location or address
505	508		that:
506	509		a. is engaged in the compounding of sterile drugs,
507	510		b. has elected to register as an outsourcing facility,
508	511		and
509		-	c. complies with all requi rements of 21 U.S.C., Section
	512	+	c. complies with all requi rements of 21 U.S.C. Section
510	513		353b;
511	514		32. 33. “Package” means the smallest individual saleable unit
512	515		of product for distribution by a manufacturer or repackager that is
513	516		intended by the manufacturer for ultimate sale to the dispenser of
514	517		such product. For the purposes of this paragraph, “individual
515	518		saleable unit” means the smallest container of a product introduced
516	519		into commerce by the manufacturer or repackager that is intended by
517	520		the manufacturer or repackager for individual sale to a dispenser;
518	521		33. 34. “Person” means an individual, partnership, limited
519	522		liability company, corporation or association, unless the context
520	523		otherwise requires;
	524	+	34. 35. “Pharmacist-in-charge” or “PIC” means the pharmacist
	525	+	licensed in this state responsible for the management control of a
521	526
522		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 11 1
	527	+	SB232 HFLR Page 11
	528	+	BOLD FACE denotes Committee Amendments. 1
523	529		2
524	530		3
525	531		4
526	532		5
527	533		6
528	534		7
529	535		8
530	536		9
531	537		10
532	538		11
533	539		12
534	540		13
535	541		14
536	542		15
537	543		16
538	544		17
539	545		18
540	546		19
541	547		20
542	548		21
543	549		22
544	550		23
545	551		24
546	552
547		-	34. 35. “Pharmacist-in-charge” or “PIC” means the pharmacist
548		-	licensed in this state responsible for the management control of a
549	553		pharmacy and all other aspects of the practice of pharmacy in a
550	554		licensed pharmacy as defined by Section 353.18 of this title;
551	555		35. 36. “Pharmacy” means a place regularly licensed by the
552	556		State Board of Pharmacy in which prescriptions, drugs, medicines,
553	557		chemicals and poisons are compounded or dispensed or such place
554	558		where pharmacists practice the profession of pharmacy, or a pharmacy
555	559		operated by the Oklahoma Department of Veterans Affairs;
556	560		36. 37. “Pharmacy technician”, “technician”, “Rx tech”, or
557	561		“tech” means a person issued a Technician permit by the State Board
558	562		of Pharmacy to assist the pharmacist and perform nonjudgmental,
559	563		technical, manipulative, non-discretionary functions in the
560	564		prescription department under the immediate and direct supervision
561	565		of a pharmacist;
562	566		37. 38. “Poison” means any substance which when introduced into
563	567		the body, either directly or by absorption, produces violent, morbid
564	568		or fatal changes, or which destroys living tissue with which such
565	569		substance comes into contact;
566	570		38. 39. “Practice of pharmacy” means:
567	571		a. the interpretation and evaluation of prescription
568	572		orders,
569	573		b. the compounding, dispensing, administering and
570	574		labeling of drugs and devices, except labeling by a
	575	+	manufacturer, repackager or distributor of
571	576
572		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 12 1
	577	+	SB232 HFLR Page 12
	578	+	BOLD FACE denotes Committee Amendments. 1
573	579		2
574	580		3
575	581		4
576	582		5
577	583		6
578	584		7
579	585		8
580	586		9
581	587		10
582	588		11
583	589		12
584	590		13
585	591		14
586	592		15
587	593		16
588	594		17
589	595		18
590	596		19
591	597		20
592	598		21
593	599		22
594	600		23
595	601		24
596	602
597		-	manufacturer, repackager or distributor of
598	603		nonprescription drugs and commercially packaged legend
599	604		drugs and devices,
600	605		c. the participation in drug selection and drug
601	606		utilization reviews,
602	607		d. the proper and safe storage of drugs and devices and
603	608		the maintenance of proper records thereof,
604	609		e. the responsibility for advising by counseling and
605	610		providing information, where professionally necessary
606	611		or where regulated, of therapeutic values, content,
607	612		hazards and use of drugs and devices,
608	613		f. the offering or performing of those acts, services,
609	614		operations or transactions necessary in the conduct,
610	615		operation, management and control of a pharmacy, or
611	616		g. the ordering, performing, and interpreting of tests
612	617		for minor, nonchronic health conditions that meet the
613	618		requirements of Section 1 of this act and the
614	619		initiation of drug therapy for minor, nonchronic
615	620		health conditions,
616	621		h. the dispensing of se lf-administered hormonal
617	622		contraceptives as provided by Section 1 of this act,
618	623		or
619	624		i. the provision of those acts or services that are
620	625		necessary to provide pharmaceutical care;
621	626
622		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 13 1
	627	+	SB232 HFLR Page 13
	628	+	BOLD FACE denotes Committee Amendments. 1
623	629		2
624	630		3
625	631		4
626	632		5
627	633		6
628	634		7
629	635		8
630	636		9
631	637		10
632	638		11
633	639		12
634	640		13
635	641		14
636	642		15
637	643		16
638	644		17
639	645		18
640	646		19
641	647		20
642	648		21
643	649		22
644	650		23
645	651		24
646	652
647	653		39. 40. “Preparation” means an article which may or may not
648	654		contain sterile produc ts compounded in a licensed pharmacy pursuant
649	655		to the order of a licensed prescriber;
650	656		40. 41. “Prescriber” means a person licensed in this state who
651	657		is authorized to prescribe dangerous drugs within the scope of
652	658		practice of the person’s profession;
653	659		41. 42. “Prescription” means and includes any order for drug or
654	660		medical supplies written or signed, or transmitted by word of mouth,
655	661		telephone or other means of communication:
656	662		a. by a licensed prescriber,
657	663		b. under the supervision of an Oklahoma licensed
658	664		practitioner, an Oklahoma licensed advanced practice
659	665		registered nurse Advanced Practice Registered Nurse or
660	666		an Oklahoma licensed physician assistant, or
661	667		c. by an Oklahoma licensed wholesaler or distributor as
662	668		authorized in Section 353.29.1 of this title;
663	669		42. 43. “Product” means a prescription drug in a finished
664	670		dosage form for administration to a patient without substantial
665	671		further manufacturing, such as capsules, tablets, and lyophilized
666	672		products before reconstitution. “Product” Product does not include
667	673		blood components intended for transfusion, radioactive drugs or
668	674		biologics and medical gas;
669	675		43. 44. “Repackager”, including “virtual repackager”, means a
670	676		person who owns or operates an establishment that repacks and
671	677
672		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 14 1
	678	+	SB232 HFLR Page 14
	679	+	BOLD FACE denotes Committee Amendments. 1
673	680		2
674	681		3
675	682		4
676	683		5
677	684		6
678	685		7
679	686		8
680	687		9
681	688		10
682	689		11
683	690		12
684	691		13
685	692		14
686	693		15
687	694		16
688	695		17
689	696		18
690	697		19
691	698		20
692	699		21
693	700		22
694	701		23
695	702		24
696	703
697	704		relabels a product or package for further sale or distribution
698	705		without further transaction;
699	706		44. 45. “Sterile drug” means a drug that is intended for
700	707		parenteral administration, an ophthalmic or oral inhalation drug in
701	708		aqueous format, or a drug that is required to be sterile under state
702	709		and federal law;
703	710		45. 46. “Supervising physician” means an individual holding a
704	711		current license to practice as a physician from the State Board of
705	712		Medical Licensure and Supervision, pursuant to the provisions of the
706	713		Oklahoma Allopathic Medical and Surgical Licensure and Supervision
707	714		Act, or the State Board of Osteopathic Examiners, pursuant to t he
708	715		provisions of the Oklahoma Osteopathic Medicine Act, who supervises
709	716		an advanced practice registered nurse Advanced Practice Registered
710	717		Nurse as defined in Section 567.3a of this title, and who is not in
711	718		training as an intern, resident, or fellow . To be eligible to
712	719		supervise an advanced practice registered nurse Advanced Practice
713	720		Registered Nurse, such physician shall remain in compliance with the
714	721		rules promulgated by the State Boar d of Medical Licensure and
715	722		Supervision or the State Board of O steopathic Examiners;
716	723		46. 47. “Supportive personnel” means technicians and auxiliary
717	724		supportive persons who are regularly paid employees of a pharmacy
718	725		who work and perform tasks in the pharmacy as authorized by Section
719	726		353.18A of this title;
720	727
721		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 15 1
	728	+	SB232 HFLR Page 15
	729	+	BOLD FACE denotes Committee Amendments. 1
722	730		2
723	731		3
724	732		4
725	733		5
726	734		6
727	735		7
728	736		8
729	737		9
730	738		10
731	739		11
732	740		12
733	741		13
734	742		14
735	743		15
736	744		16
737	745		17
738	746		18
739	747		19
740	748		20
741	749		21
742	750		22
743	751		23
744	752		24
745	753
746	754		47. 48. “Third-party logistics provider” including “virtual
747	755		third-party logistics provider” means an entity that provides or
748	756		coordinates warehousing, or other logistics services of a product in
749	757		interstate commerce on behalf of a manufacturer, wholesale
750	758		distributor, or dispenser of a product but does not take ownership
751	759		of the product, nor have responsibility to direct the sale or
752	760		disposition of the product. For the purposes of this paragraph,
753	761		“third-party logistics provider” third-party logistics provider does
754	762		not include shippers and the United States Postal Service;
755	763		48. 49. “Wholesale distributor” including “virtual wholesale
756	764		distributor” means a person other than a manufacturer, a
757	765		manufacturer’s co-licensed partner, a third-party logistics
758	766		provider, or repackager engaged in wh olesale distribution as defined
759		-	by 21 U.S.C., Section 353(e)(4) as amended by the Drug Supply Chain
	767	+	by 21 U.S.C. Section 353(e)(4) as amended by the Drug Supply Chain
760	768		Security Act;
761	769		49. 50. “County jail” means a facility operated by a county for
762	770		the physical detention and correction of persons charged with, or
763	771		convicted of, criminal o ffenses or ordinance violations or persons
764	772		found guilty of civil or criminal contempt;
765	773		50. 51. “State correctional facility” means a facility or
766	774		institution that houses a p risoner population under the jurisdiction
767	775		of the Department of Corrections;
768	776
769		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 16 1
	777	+	SB232 HFLR Page 16
	778	+	BOLD FACE denotes Committee Amendments. 1
770	779		2
771	780		3
772	781		4
773	782		5
774	783		6
775	784		7
776	785		8
777	786		9
778	787		10
779	788		11
780	789		12
781	790		13
782	791		14
783	792		15
784	793		16
785	794		17
786	795		18
787	796		19
788	797		20
789	798		21
790	799		22
791	800		23
792	801		24
793	802
794	803		51. 52. “Unit dose package” means a package that contains a
795	804		single dose drug with the name, strength, control number, and
796	805		expiration date of that drug on the label; and
797	806		52. 53. “Unit of issue package” means a package that provides
798	807		multiple doses of the same drug , but each drug is individually
799	808		separated and includes the name, lot number, and expirat ion date.
800	809		SECTION 3. AMENDATORY 59 O. S. 2021, Section 353.18A, is
801	810		amended to read as follows:
802	811		Section 353.18A A. Supportive personnel may p erform certain
803	812		tasks in the practice of pharma cy if such personnel perform the
804	813		tasks in compliance with rules pro mulgated by the State Board of
805	814		Pharmacy.
806	815		B. 1. No person shall serve as a pharmacy technician without
807	816		first procuring a permit from the Board .
808	817		2. An application for an initial or renewal pharmacy technician
809	818		permit issued pursuant to the provisions of th is subsection shall be
810	819		submitted to the Board and provide any other information deemed
811	820		relevant by the Board.
812	821		3. An application for an initial or renewal permit shall be
813	822		accompanied by a permit fee not to exceed Seventy Five Seventy-five
814	823		Dollars ($75.00) for each period of one (1) year. A permit issued
815	824		pursuant to this subsection shall be valid for a period to be
816	825		determined by the Board.
817	826
818		-	ENGR. H. A. to ENGR. S. B. NO. 232 Page 17 1
	827	+	SB232 HFLR Page 17
	828	+	BOLD FACE denotes Committee Amendments. 1
819	829		2
820	830		3
821	831		4
822	832		5
823	833		6
824	834		7
825	835		8
826	836		9
827	837		10
828	838		11
829	839		12
830	840		13
831	841		14
832	842		15
833	843		16
834	844		17
835	845		18
836	846		19
837	847		20
838	848		21
839	849		22
840	850		23
841	851		24
842	852
843	853		4. Every permitted pharmacy technician who fails to complete a
844	854		renewal form and remit the requi red renewal fee to the Board by the
845	855		fifteenth day after the expiration of the permit shall pay a late
846	856		fee to be fixed by the Board.
847	857		5. A pharmacy technician permit s hall be cancelled canceled
848	858		thirty (30) days after expiration.
849	859		6. A person may obtain rein statement of a cancelled canceled
850	860		pharmacy technician permit by making application, paying a
851	861		reinstatement fee, and satisfactorily completing other requirements
852	862		set by the Board.
853	863		C. A licensed pharmacy s hall maintain a pharmacy technician-to-
854	864		pharmacist ratio of not more than three pharmacy technicians for
855		-	every one licensed pharmacist."
856		-	Passed the House of Representatives the 25th day of April, 2024.
	865	+	every one licensed pharmacist.
	866	+	SECTION 4. This act shall become effective July 1, 2024.
	867	+	SECTION 5. It being immediately necessary for the preservation
	868	+	of the public peace, health or safety, an emergency is hereby
	869	+	declared to exist, by reason whereof this act shall t ake effect and
	870	+	be in full force from and after its passage and approval.
857	871
858		-
859		-
860		-
861		-
862		-	Presiding Officer of the House of
863		-	Representatives
864		-
865		-
866		-	Passed the Senate the ____ day of _______ ___, 2024.
867		-
868		-
869		-
870		-
871		-
872		-	Presiding Officer of the Senate
873		-
874		-	ENGR. S. B. NO. 232 Page 1 1
875		-	2
876		-	3
877		-	4
878		-	5
879		-	6
880		-	7
881		-	8
882		-	9
883		-	10
884		-	11
885		-	12
886		-	13
887		-	14
888		-	15
889		-	16
890		-	17
891		-	18
892		-	19
893		-	20
894		-	21
895		-	22
896		-	23
897		-	24
898		-
899		-	ENGROSSED SENATE
900		-	BILL NO. 232 By: Garvin of the Senate
901		-
902		-	and
903		-
904		-	McEntire of the House
905		-
906		-
907		-
908		-
909		-	[ pharmacy - technicians - ratio - effective date ]
910		-
911		-
912		-
913		-
914		-
915		-	BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
916		-	SECTION 4. AMENDATORY 59 O. S. 2021, Section 353.18A, is
917		-	amended to read as follows:
918		-	Section 353.18A. A. Supportive personnel may perform certain
919		-	tasks in the practice of pharmacy if such personnel perform the
920		-	tasks in compliance with rules promulgated by the State Board of
921		-	Pharmacy.
922		-	B. 1. No person shall serve as a pharmacy technician without
923		-	first procuring a permit from the Board.
924		-	2. An application for an initial or renewal pharmacy technician
925		-	permit issued pursuant to the provisions of this subsection shall be
926		-	submitted to the Board and provide any other information deemed
927		-	relevant by the Board.
928		-	3. An application for an initial or renewal permit shall be
929		-	accompanied by a permit fee not to exceed Seventy Five Seventy-five
930		-	Dollars ($75.00) for each period of one (1) year. A pe rmit issued
931		-
932		-	ENGR. S. B. NO. 232 Page 2 1
933		-	2
934		-	3
935		-	4
936		-	5
937		-	6
938		-	7
939		-	8
940		-	9
941		-	10
942		-	11
943		-	12
944		-	13
945		-	14
946		-	15
947		-	16
948		-	17
949		-	18
950		-	19
951		-	20
952		-	21
953		-	22
954		-	23
955		-	24
956		-
957		-	pursuant to this subsection shall be valid for a period to be
958		-	determined by the Board.
959		-	4. Every permitted pharmacy technician who fails to complete a
960		-	renewal form and remit the required renewal fee to the Board by the
961		-	fifteenth day after the e xpiration of the permit shall pay a late
962		-	fee to be fixed by the Board.
963		-	5. A pharmacy technician permit shall be cancelled canceled
964		-	thirty (30) days after expiration.
965		-	6. A person may obtain reinstatement of a cancelled canceled
966		-	pharmacy technician permit by making application, paying a
967		-	reinstatement fee, and satisfactorily complet ing other requirements
968		-	set by the Board.
969		-	C. A licensed pharmacy s hall maintain a pharmacy technician -to-
970		-	pharmacist ratio of not more than five pharmacy technicians for
971		-	every one licensed pharmacist.
972		-	SECTION 5. This act shall become effect ive November 1, 2024.
973		-
974		-	ENGR. S. B. NO. 232 Page 3 1
975		-	2
976		-	3
977		-	4
978		-	5
979		-	6
980		-	7
981		-	8
982		-	9
983		-	10
984		-	11
985		-	12
986		-	13
987		-	14
988		-	15
989		-	16
990		-	17
991		-	18
992		-	19
993		-	20
994		-	21
995		-	22
996		-	23
997		-	24
998		-
999		-	Passed the Senate the 11th day of March, 2024.
1000		-
1001		-
1002		-
1003		-	Presiding Officer of the Senate
1004		-
1005		-
1006		-	Passed the House of Representatives the ____ day of __________,
1007		-	2024.
1008		-
1009		-
1010		-
1011		-	Presiding Officer of the House
1012		-	of Representatives
1013		-
1014		-
	872	+	COMMITTEE REPORT BY: COMMITTEE ON BUSINESS AND COMMERCE, dated
	873	+	04/10/2024 - DO PASS, As Amended.